New treatment to slow muscle wastag… – Information Centre – Research & Innovation

A medication produced by EU-funded researchers has been authorised to address little ones with the degenerative and lethal genetic sickness Duchenne muscular dystrophy. A main medical trial is expected to announce good benefits soon. © All rights reserved. | Magazine 7 by AF themes.